Have a personal or library account? Click to login
Diagnostic imaging of gastrointestinal neuroendocrine neoplasms with a focus on ultrasound Cover

Diagnostic imaging of gastrointestinal neuroendocrine neoplasms with a focus on ultrasound

Open Access
|Sep 2019

References

  1. Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, Bałdys-Waligórska A, Bednarczuk T, Bolanowski M et al.: Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 79–110.
  2. Bodei L, Sundin A, Kidd M, Prasad V, Modlin IM: The status of neuroendocrine tumor imaging: from darkness to light? Neuroendocrinology 2015; 101: 1–17.
  3. Maxwell JE, Howe JR: Imaging in neuroendocrine tumors: an update for the clinician. Int J Endocr Oncol 2015; 2: 159–168.
  4. Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA: Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 2013; 266: 38–61.
  5. Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC: Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer 2008; 123: 867–873.
  6. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM: The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 2011; 40: 1–18.
  7. Toumpanakis CG, Caplin ME: Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Am J Gastroenterol 2008; 103: 729–732.
  8. Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H: Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol 2008; 15: 165–171.
  9. Lodish MB, Stratakis CA: Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab 2010; 24: 439–449.
  10. Tsujimura K, Takushi Y, Teruya T, Iha K, Ota M, Nakachi A et al.: Neuroendocrine tumor of the small intestine diagnosed with trans-abdominal ultrasonography: A case report. Int J Surgery Case Reports 2017; 31: 75–78.
  11. Miller HC, Frampton AE, Malczewska A, Ottaviani S, Stronach EA, Flora R et al.: MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. Endocr Relat Cancer 2016; 23: 711–726.
  12. Bednarczuk T, Bolanowski M, Zemczak A, Bałdys-Waligórska A, Blicharz-Dorniak J, Boratyn-Nowicka A et al.: Neuroendocrine neoplasms of the small intestine and the appendix – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 223–236.
  13. Tan EH, Tan CH: Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2011; 2: 28–43.
  14. Kong WT, Ji ZB, Wang WP, Cai H, Huang BJ, Ding H: Evaluation of liver metastases using contrast-enhanced ultrasound: enhancement patterns and influencing factors. Gut Liver 2016; 10: 283–287.
  15. Braden B, Jenssen Ch, D’Onofrio M, Hocke M, Will U, Möller K et al.: B-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors. Endosc Ultrasound 2017; 6: 49–54.
  16. Dietrich CF, Ignee A, Braden B, Barreiros AP, Ott M, Hocke M: Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008; 6: 590–597.
  17. Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M et al.: Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastroentero-pancreatic tumours. Eur J Nucl Med 1998; 25: 1396–1403.
  18. Kos-Kudła B, Rosiek V, Borowska M, Bałdys-Waligórska A, Bednarczuk T, Blicharz-Dorniak J et al.: Pancreatic neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 169–197.
  19. Starzyńska T, Londzin-Olesik M, Bałdys-Waligórska A, Bednarczuk T, Blicharz-Dorniak J, Bolanowski M et al.: Colorectal neuroendocrine neoplasms – management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017; 68: 250–260.
  20. Sun Bo, Hu B: The role of intraductal ultrasonography in pancreatobiliary diseases. Endosc Ultrasound 2016; 5: 291–299.
  21. Nemakayala D, Patel P, Rahimi E, Fallon MB, Thosani N: Use of quantitative endoscopic ultrasound elastography for diagnosis of pancreatic neuroendocrine tumors. Endosc Ultrasound 2016; 5: 342–345.
  22. Iglesias-Garcia J, Larino-Noia J, Abdulkader I, Forteza J, Dominguez-Munoz JE: Quantitative endoscopic ultrasound elastography: An accurate method for the differentiation of solid pancreatic masses. Gastroenterology 2010; 139: 1172–1180.
DOI: https://doi.org/10.15557/jou.2019.0034 | Journal eISSN: 2451-070X | Journal ISSN: 2084-8404
Language: English
Page range: 228 - 235
Submitted on: Mar 23, 2019
|
Accepted on: Jun 26, 2019
|
Published on: Sep 30, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Joanna Walczyk, Anna Sowa-Staszczak, published by MEDICAL COMMUNICATIONS Sp. z o.o.
This work is licensed under the Creative Commons Attribution 4.0 License.